Endogenous panophthalmitis in a patient with COVID-19 during hospitalization in an intensive care unit: A case report.
Am J Ophthalmol Case Rep
; 28: 101707, 2022 Dec.
Article
in English
| MEDLINE | ID: covidwho-2031085
ABSTRACT
Purpose:
To report a case of endogenous panophthalmitis in a patient with COVID-19 during treatment in an Intensive Care Unit. Observation A 64-year-old woman with COVID-19 and Salmonella septicemia presented with decreased visual acuity, ocular pain, and proptosis in her right eye after treatment with favipiravir, intravenous dexamethasone, and ceftriaxone. An ocular examination of her right eye revealed periorbital tenderness, exophthalmos, and corneal haze. The ultrasonography showed a subretinal abscess. Her right eye lost light perception vision and underwent enucleation. Microbiologic evaluation of the enucleated right eye was negative for organisms. Conclusions and importance Patents with COVID-19 may develop severe ocular involvement after COVID-19 due to a generalized reduction in immunity. Comorbidities and intensive care unit treatments can predispose COVID-19 patients to endogenous panophthalmitis.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
/
Experimental Studies
/
Observational study
/
Prognostic study
Language:
English
Journal:
Am J Ophthalmol Case Rep
Year:
2022
Document Type:
Article
Affiliation country:
J.ajoc.2022.101707
Similar
MEDLINE
...
LILACS
LIS